| Trial ID: | L6237 |
| Source ID: | NCT00747409
|
| Associated Drug: |
Insulin Aspart And Detemir (Novorapid, Levemir)
|
| Title: |
Insulin Effects on Metabolism and Cardiovascular Function in Type 2 Diabetes
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: insulin aspart and detemir (NovoRapid, Levemir)|DRUG: human regular insulin and NPH insulin (Actrapid, Protaphne)
|
| Outcome Measures: |
Primary: postprandial blood glucose at the end of the study and its change from baseline., 24-48 months treatment period | Secondary: diastolic myocardial function, 24-48 months treatment
|
| Sponsor/Collaborators: |
Sponsor: Munich Municipal Hospital | Collaborators: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
120
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2004-07
|
| Completion Date: |
2009-06
|
| Results First Posted: |
|
| Last Update Posted: |
2008-09-05
|
| Locations: |
Staedt. Klinikum Muenchen Bogenhausen, Munich, Bavaria, 81925, Germany
|
| URL: |
https://clinicaltrials.gov/show/NCT00747409
|
